Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FOREX-Dollar falls on Biden transition, vaccine hopes; kiwi soars

Tue, 24th Nov 2020 12:09

* Graphic: World FX rates in 2020 https://tmsnrt.rs/2RBWI5E

By Saikat Chatterjee

LONDON, Nov 24 (Reuters) - The Australian dollar rose to a
two-and-a-half-month high and the euro gained on Tuesday as U.S.
President Donald Trump accepted the transition to a Joseph Biden
presidency, which may include former Federal Reserve Chair Janet
Yellen as Treasury secretary.

Appetite for riskier assets was evident across the board.
Stocks and oil rose as progress made on COVID-19 vaccines, which
had underpinned Wall Street overnight, boosted optimism about a
quicker revival for the global economy.

Trump acknowledged the head of the General Services
Administration should go ahead with a transition to a government
led by President-elect Biden, despite plans to continue with
legal challenges.

Democratic allies to the Biden campaign said Yellen is
expected to be nominated to become Treasury Secretary. She has
called for increased government spending to lift the economy out
of a coronavirus-induced recession.

"That should be a positive appointment from the market’s
point of view, as she is expected to pursue conventional
policies," Commerzbank strategists said in a daily note.

"And as far as the fiscal package is concerned, she is
likely to listen to the Fed's demands and try and push a package
as much as possible."

Yellen has called for more fiscal spending to revive an
economy wrecked by the coronavirus pandemic. She would be the
first person to head the Treasury, the Fed and the White House
Council of Economic Advisers.

In contrast, U.S. Treasury Secretary Steven Mnuchin last
week let some of the Fed's lending programmes expire at the end
of this year, opening a feud with the central bank, which said
those emergency facilities are important to support the economy.

Against a basket of other major currencies, the
dollar weakened 0.4% to 92.13, just above Monday's 92.013, the
lowest in nearly three months.

The Australian dollar climbed 0.9% to $0.7367. The
euro gained 0.4% at $1.1894.

The euro's gains will be a concern for policymakers at
December's meeting of the European Central Bank. German Ifo data
and PMI surveys showed the European economy is struggling amid
lockdowns to slow a second wave of coronavirus
infections.

The dollar also struggled after AstraZeneca said its
COVID-19 vaccine could be about 90% effective and it would
prepare to submit data to authorities around the world,
increasing demand for risky assets.

The New Zealand dollar rose as much as 1% to a
two-year high of $0.6985, after the country's government sought
advice from the central bank on how it could help stabilise
property prices, prompting investors to unwind some bets of more
easing.

Elsewhere, cryptocurrency Bitcoin scaled a near
three-year peak of $19,000.

(Reporting by Saikat Chatterjee; Additional reporting by
Hideyuki Sano in Tokyo; editing by Kirsten Donovan, Larry King)

More News
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.